Signed MOU on October 18, 2015, with an unnamed leading PCB manufacturer for exclusive use of Sicrys inks in mass production of PCBs via digital inkjet printing, with inks free for the first 3 months and PV Nano Cell providing a printer at cost.
Major Milestones
2010: Founded in Migdal, Israel; Developed Sicrys silver-based conductive inks; 2020: Strategic partnership with Notion Systems; Multiple patents granted in USA, Russia, China, Japan, Europe, Israel, Brazil; Successfully participated in HiperLAM EU project; Introduced 5D Electronics of Things solution
Series A$3.5M2013-08Lead: Infinity IP Bank (China) · Source: PR Newswire
Why this company matters
AMPulse analysis, not a company disclosure
PV Nano Cell develops single nano crystal conductive inks for mass-produced inkjet-based printed electronics. Founded in 2008 in Migdal HaEmek, Israel, the company positions itself as a complete solution provider offering inks, printers, and process support, differentiating from materials-only suppliers like DuPont and Henkel.
The core technology is patented single nano crystal conductive inks, sold under the Sicrys brand for silver and as copper conductive inks. Unlike particle-based inks, the single crystal structure enables higher stability and throughput in inkjet printing. The company also supplies inkjet production printers and has a strategic partnership with Notion Systems for digital printed electronics.
Target customers include electronics manufacturers, PCB fabricators, solar cell makers, and IoT device producers. PV Nano Cell has participated in the EU-funded HiperLAM project for RFID antennas and fingerprint sensors and signed a memorandum of understanding with an unnamed leading PCB manufacturer for exclusive use of Sicrys inks in mass production. Joint patents with Tel-Aviv University cover nanowire technology.
Key investors include Infinity IP Bank (China), Israel Electric Corporation, Slobel (Belgium), Terra Venture Partners, and JetCu P.C.B. Ltd. The company has raised $5.77 million in total funding. CEO Dr. Fernando de la Vega leads a team of 11-50 employees. The main competitive risk is adoption rate versus established particle-based ink alternatives from larger chemical firms.